Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights • The role of plasma therapeutics in critical care industry • Introduction to plasma therapeutics • Introduction to anticoagulants PART 05: Global critical care therapeutics: Market landscape • Market overview • Five forces analysis PART 06: Market segmentation by drug class • Global albumin market • Global prothrombin complex concentrates market • Global antithrombin concentrates market • Global factor XIII concentrates market • Global fibrinogen concentrates market PART 07: Market segmentation by application • DVT • Pulmonary embolism (PE) • Acute coronary syndrome • Atrial fibrillation • Hemodialysis • Coronary angioplasty • Surgeries PART 08: Geographical segmentation • Critical care therapeutics market in Americas • Critical care therapeutics market in EMEA • Critical care therapeutics market in APAC PART 09: Market drivers • High demand for albumin in China • Increasing surgical procedures • Growing preference for marketed products over alternative treatment options • Impact of drivers PART 10: Market challenges • Existence of plasma fractionation supply and demand gap • Spread of pathogenic contaminants • High regulations of plasma products PART 11: Impact of drivers and challenges PART 12: Market trends • Increased development of recombinant products for critical care use • Establishment of plasma fractionation facilities in emerging economies by global players • Strategic initiatives of vendors fueling the market growth PART 13: Vendor landscape • Competitive scenario • Other prominent vendors PART 14: Key vendor analysis • CSL Behring • Grifols • Kedrion Biopharma • Octapharma • Shire PART 15: Appendix • List of abbreviations PART 16: Explore Technavio0 List of Exhibits Exhibit 01: Composition of blood Exhibit 02: Composition of plasma Exhibit 03: Process of procurement and manufacturing of plasma therapeutics Exhibit 04: Regulatory policies of plasma therapeutics life cycle Exhibit 05: Process of blood coagulation Exhibit 06: Mechanism of blood coagulation Exhibit 07: Market snapshot of global critical care therapeutic market Exhibit 08: Overview of global critical care therapeutic market 2016-2021 Exhibit 09: Global critical care therapeutic market snapshot: Developed and emerging market 2016-2021 Exhibit 10: Global critical care therapeutics market 2016-2021 ($ millions) Exhibit 11: Opportunity analysis in global critical care therapeutics market Exhibit 12: Five forces analysis Exhibit 13: Market segmentation of global critical care therapeutics by drug class Exhibit 14: Overview of global albumin market Exhibit 15: Overview of global prothrombin complex concentrates market Exhibit 16: Overview of antithrombin concentrates market Exhibit 17: Overview of global factor XIII concentrates market Exhibit 18: Overview of global fibrinogen concentrates market Exhibit 19: Global critical care therapeutics market: Segmentation by geography 2016-2021 Exhibit 20: Global critical care therapeutics market segmentation by region: Market growth life cycle analysis 2016 Exhibit 21: Overview of critical care therapeutics market in Americas Exhibit 22: Critical care therapeutics market in Americas 2016-2021 ($ millions) Exhibit 23: Opportunity analysis of critical care therapeutics market in Americas Exhibit 24: Pest analysis of critical care therapeutics market in Americas Exhibit 25: Overview of critical care therapeutics market in EMEA Exhibit 26: Critical care therapeutics market in EMEA 2016-2021 ($ millions) Exhibit 27: Opportunity analysis of critical care therapeutics market in EMEA Exhibit 28: Pest analysis of critical care therapeutics market in EMEA Exhibit 29: Overview of critical care therapeutics market in APAC Exhibit 30: Critical care therapeutics market in APAC 2016-2021 ($ millions) Exhibit 31: Opportunity analysis of critical care therapeutics market in APAC Exhibit 32: Pest analysis of critical care therapeutics market in APAC Exhibit 33: Impact of drivers and challenges on global critical care therapeutics market Exhibit 34: Impact of drivers Exhibit 35: Demand and supply gap: Plasma-derived products (million liters/year) Exhibit 36: Impact of drivers and challenges Exhibit 37: Impact of trends on global critical care therapeutics market Exhibit 38: Overview of critical care therapeutics: M&A and licensing partnerships 2005-2012 Exhibit 39: Competitive structure analysis of global critical care therapeutics market 2016 Exhibit 40: Competitive analysis of global critical care therapeutics market Exhibit 41: Market penetration of various plasma products manufacturers worldwide 2016 Exhibit 42: CSL Behring: Key highlights Exhibit 43: CSL Behring: Strength assessment Exhibit 44: CSL Behring: Strategy assessment Exhibit 45: CSL Behring: Opportunity assessment Exhibit 46: Grifols: Key highlights Exhibit 47: Grifols: Strength assessment Exhibit 48: Grifols: Strategy assessment Exhibit 49: Grifols: Opportunity assessment Exhibit 50: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions) Exhibit 51: Kedrion Biopharma: Key highlights Exhibit 52: Kedrion Biopharma: Strength assessment Exhibit 53: Kedrion Biopharma: Strategy assessment Exhibit 54: Kedrion Biopharma: Opportunity assessment Exhibit 55: Octapharma: Key highlights Exhibit 56: Octapharma: Strength assessment Exhibit 57: Octapharma: Strategy assessment Exhibit 58: Octapharma: Opportunity assessment Exhibit 59: Shire: Key highlights Exhibit 60: Shire: Strength assessment Exhibit 61: Shire: Strategy assessment Exhibit 62: Shire: Opportunity assessment

CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Shire, Abeona Therapeutics, ADMA Biologics, Albumedix, Armetheon, Asklepios BioPharmaceutical, Aspen Pharma, Baxter, Bayer HealthCare, Bio Products Laboratory, BioDelivery Sciences, Biogen Idec, BioMarin, Biotest Pharmaceuticals, Bristol-Myers Squibb, Catalyst Biosciences, China Biologic Products, Cosmo Pharmaceuticals, Kamada, King Pharmaceuticals, Medxbio, Merck, Mitsubishi Tanabe Pharma, Novo Nordisk, Novozymes, Portola Pharmaceuticals, ProMetic Life Sciences, rEVO Biologics, Rockwell Medical, Sanquin, Shanghai RAAS, Teva Pharmaceutical, The Medicines Company, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience.